Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lidocaine vs dexmedetomidine vs saline for recovery after thyroid surgery
ChiCTR2000038442Phase 4Recruiting
- Sponsor
- Anqing City Hospital
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of lidocaine and dexmedetomidine in thyroid neoplasm (3 arms), sponsored by Anqing City Hospital. Primary endpoint: Quality of recovery (QoR-15 scale). Started Sep 2020; status: recruiting.
02
Drugs
lidocainedexmedetomidine
03
Conditions
thyroid neoplasm
Beyond the preview
Go deeper on ChiCTR2000038442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000038442.